ProfileGDS4814 / ILMN_1730811
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 6% 1% 2% 2% 8% 2% 3% 13% 3% 1% 5% 1% 1% 4% 1% 5% 5% 3% 1% 5% 1% 12% 4% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)39.64616
GSM780708Untreated after 4 days (C2_1)35.71541
GSM780709Untreated after 4 days (C3_1)37.85032
GSM780719Untreated after 4 days (C1_2)37.49152
GSM780720Untreated after 4 days (C2_2)40.47738
GSM780721Untreated after 4 days (C3_2)37.34282
GSM780710Trastuzumab treated after 4 days (T1_1)38.29163
GSM780711Trastuzumab treated after 4 days (T2_1)42.041813
GSM780712Trastuzumab treated after 4 days (T3_1)38.43553
GSM780722Trastuzumab treated after 4 days (T1_2)36.53091
GSM780723Trastuzumab treated after 4 days (T2_2)39.4335
GSM780724Trastuzumab treated after 4 days (T3_2)33.90481
GSM780713Pertuzumab treated after 4 days (P1_1)34.08761
GSM780714Pertuzumab treated after 4 days (P2_1)38.77924
GSM780715Pertuzumab treated after 4 days (P3_1)36.68991
GSM780725Pertuzumab treated after 4 days (P1_2)39.28985
GSM780726Pertuzumab treated after 4 days (P2_2)39.6035
GSM780727Pertuzumab treated after 4 days (P3_2)38.3443
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)34.88041
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)39.46085
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)35.831
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)41.734212
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)38.78414